GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krka DD (XLJU:KRKG) » Definitions » Return-on-Tangible-Equity

Krka DD (XLJU:KRKG) Return-on-Tangible-Equity : 10.84% (As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Krka DD Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Krka DD's annualized net income for the quarter that ended in Sep. 2024 was €237 Mil. Krka DD's average shareholder tangible equity for the quarter that ended in Sep. 2024 was €2,186 Mil. Therefore, Krka DD's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 was 10.84%.

The historical rank and industry rank for Krka DD's Return-on-Tangible-Equity or its related term are showing as below:

XLJU:KRKG' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 8.29   Med: 14.5   Max: 19.04
Current: 17

During the past 13 years, Krka DD's highest Return-on-Tangible-Equity was 19.04%. The lowest was 8.29%. And the median was 14.50%.

XLJU:KRKG's Return-on-Tangible-Equity is ranked better than
76.38% of 906 companies
in the Drug Manufacturers industry
Industry Median: 6.53 vs XLJU:KRKG: 17.00

Krka DD Return-on-Tangible-Equity Historical Data

The historical data trend for Krka DD's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krka DD Return-on-Tangible-Equity Chart

Krka DD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.47 18.24 17.99 19.04 15.41

Krka DD Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.61 15.53 18.77 22.17 10.84

Competitive Comparison of Krka DD's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Krka DD's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krka DD's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krka DD's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Krka DD's Return-on-Tangible-Equity falls into.


;
;

Krka DD Return-on-Tangible-Equity Calculation

Krka DD's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=313.946/( (2016.066+2059.707 )/ 2 )
=313.946/2037.8865
=15.41 %

Krka DD's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=236.816/( (2285.713+2085.34)/ 2 )
=236.816/2185.5265
=10.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Krka DD  (XLJU:KRKG) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Krka DD Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Krka DD's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Krka DD Business Description

Traded in Other Exchanges
Address
Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of its revenue from the European Union.

Krka DD Headlines

No Headlines